![Akhil Santhosh: Perioperative IO Strategy in Checkmate-816 and Checkmate-77](https://oncodaily.com/pub/uploads/2024/11/Cancer-immunotherapy-concept-Shutterstock_Lightspring.jpg)
Jan 7, 2025, 11:00
Akhil Santhosh: Perioperative IO Strategy in Checkmate-816 and Checkmate-77
Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, shared on X:
“IPD analysis from checkmate 816 and checkmate 77T shows that periop IO strategy as in checkmate 77T had a benefit over neoadjuvant only approach in patients with pdl1 score<1% and non-path CR achievers.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 13, 2025, 09:30
Feb 13, 2025, 09:29
Feb 13, 2025, 09:23
Feb 13, 2025, 09:17
Feb 13, 2025, 09:12
Feb 13, 2025, 09:10
Feb 13, 2025, 09:06
Feb 13, 2025, 08:58
Feb 13, 2025, 08:53